Podcasts

Dr. Alison Van Dyke and Dr. Darrell Kirch share their journeys through mental health challenges and discuss the pervasive issue of physician burnout. With a focus on breaking the stigma, they explore the importance of seeking help, fostering open conversations, and building supportive communities. They also highlight systemic changes in medical training and healthcare environments that promote wellness.

Dr. Juanita Evans interviews Dr. Michael Williams on his journey of building a platform to amplify diverse voices in pathology. Together, they discuss the challenges and triumphs of fostering inclusivity in healthcare, highlighting how representation reshapes patient care, medical education, and the future of medicine.

Insurer interference is on the rise, creating barriers for patients to access medical care. Insurer interference often happens under the guise of cost-cutting measures for patients, but pathologists report an increase in disruptions to providing timely diagnosis and medical care for their patients.

Dr. Joel Moncur is joined by a panel of distinguished experts to discuss the groundbreaking journey of molecular proficiency testing programs, including next-generation sequencing (NGS). Drs. Wayne Grody, Karl Voelkerding, and Jason Merker discuss the impact these programs have on laboratories, patient care, and regulatory compliance, as well as the role of molecular pathology in shaping the future of health care.

Dr. Gladell Paner speaks with two GI and liver pathologists, Dr. William Chopp and Dr. John Hart, as they explore the use of the CAP hepatocellular carcinoma (HCC) reporting protocol in both academic and private practice settings.

The perception of pathology as one of medicine's best-kept secrets underscores the growing concern that medical students are not exposed to it early enough. To highlight the specialty's clinical importance, Dr. Swati Bhardwaj recently sat down with several CAP members to talk about current efforts to improve pathology education in U.S. medical schools and address gaps in histology knowledge.

Drs. David Sacks and Andy Hoofnagle discuss the history and evolution of CAP's accuracy-based proficiency testing (PT) programs, which use advanced techniques to ensure lab results meet rigorous national and international standards.

Optical genome mapping evaluates the fluorescent labeling pattern of individual DNA molecules with a resolution far exceeding conventional cytogenetic approaches like FISH and karyotyping. In this episode, Dr. Annette Kim, MD, FCAP, and Dr. Adrian Dubuc, MD, FCAP, discuss OGM's advantages, as well as some of its current limitations.

Dr. Esther Yoon, Dr. Hafsa Nebbache, and Dr. Jennifer Woo discuss their personal experiences, survey insights, and strategies for building strong relationships with clinicians, handling challenging conversations, and improving patient care through better communication.

In this episode, we will discuss the FDA's LDT final rule and the CAP’s ongoing advocacy efforts to protect pathologists and ensure patients have access to the tests they need for quality care.

In this CAPcast episode, Gladell Paner, MD, FCAP, discusses the renaming of low-grade prostate cancer with genitourinary pathologists Ming Zhou, MD, FCAP, and Rajal Shah, MD, FCAP. They explore the history, benefits, and challenges of removing the cancer label from Grade Group 1 prostate cancer and its potential impact on patient care, pathologist practices, and the broader healthcare system.

Dr. Alexis Peedin and Dr. Melissa George discuss blood bank lookbacks, which occur in the rare instances when unsuitable blood products are unknowingly collected and transfused.

Join Gladell Paner, MD, FCAP, as he delves into inherited cancer syndromes with surgical pathologist Vania Nosé, MD, FCAP, and oncologist Mark Lewis, MD, who is also a cancer survivor. Dr. Nosé explores the genetic and clinical aspects of multiple endocrine neoplasia type 1 (MEN1), while Dr. Lewis shares his personal journey with the condition.

Dr. Kalisha Hill and Dr. Kamran Mirza discuss how future pathologist champions are working to prevent a pathologist shortage by inspiring medical students to pursue pathology.

Dr. Diana Cardona and Dr. Harry Hwang explore format and verbiage changes that could make pathology reports work for both patients and other clinicians, without burdening pathologists.

Donald Karcher, MD, FCAP, the CAP’s President and Joe Saad, MD, FCAP, President, Surgical Pathologists of Dallas presented congressional staff with CAP’s concerns that the FDA is moving forward with its regulatory oversight plan for LDTs without making the additional changes needed to ensure both patient safety and access to accurate and innovative testing.

Gladell Paner, MD, FCAP, speaks with dermatopathologists Wonwoo Shon, DO, FCAP, and Christopher Kinonen, MD, MBA, FCAP.

Since 1989, the CAP has led the way in developing new programs to ensure the quality and accuracy of laboratory testing for infectious diseases, including SARS CoV-2, Zika testing, and more.

The CAP’s Laboratory Preparedness Exercise helps laboratories assess and enhance their readiness for bioterrorism incidents, as well as natural emergencies, disasters, and other challenging situations.

Dr. Sang Wu is speaker of the CAP's House of Delegates and Dr. Mary Le, vice chair for the CAP Federal and State Affairs Committee revisit the 2024 Pathologists Leadership Summit and Hill Day.